ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2015 American Transplant Congress

    Toxoplasmosis Post-Kidney Or Liver Transplantation: A Serie of Cases

    L. Pierrotti, R. Salles, M. Rytholz, L. Azevedo, A. Song, L. D'Albuquerque, E. David-Neto, W. Nahas, E. Abdala.

    Infectious Diseases, Kidney and Digestive Organs Transplantatiion, Hospital das Clínicas, School of Medicine, University of São Paulo, São Paulo, Brazil.

    Toxoplasmosis is a rare complication post-SOT, occurring mostly in D+/R- mismatch. However, in highly endemic areas, the disease occurs predominantly in R+ under post-tx immunosuppressive…
  • 2015 American Transplant Congress

    Pretransplant Elevated Plasma Fibrinogen Level Is Associated With Tumor Recurrence and Poor Prognosis in Hepatocellular Carcinoma Patients After Liver Transplantation

    G.-Y. Wang, Y. Yang, H. Li, S.-H. Yi, G.-H. Chen.

    Department of Hepatic Surgery and Liver Transplant Center, Third Affiliated Hospital, Sun Yat-sen University, Organ Transplantation Institution of Sun Yat-sen University, Guangzhou, China.

    Background and Objective: Elevated plasma fibrinogen (FBG) level is associated with tumor progression and poor patient outcomes in several cancers. The aim of this study…
  • 2015 American Transplant Congress

    Regional Mismatch Between Liver Supply and Demand: An Argument for a More Open Market

    J. Lai, S. Sen, J. Dodge, H. Hayssen, J. Roberts.

    UCSF, San Francisco, CA.

    Background: Geographic disparities in liver transplantation (LT) are well recognized. But the degree to which regional variation in deceased donor deficits contributes to wait-list mortality…
  • 2015 American Transplant Congress

    Long-Term Outcome of Liver Transplant Recipients (OLT) With Hepatitis C Recurrence (HCVR) Who Achieved Postoperative Sustained Virologic Response (SVR) After Combination Antiviral Therapy (Rx) With and Without the Use of Telaprevir (TVR): A Single Center Experience

    C. Fasola, P. Mantry, J. Weinstein, H. Nazario, A. Mubarak, M. Barnes, A. Habib, A. Mejia, R. Dickerman, S. Cheng.

    Liver Institute, Methodist Dallas Medical Center, Dallas, TX.

    Aim: Liver allografts of viremic OLT have a higher risk of failure. Timely intervention is necessary. However, long-term outcome reports, especially using newer agents, is…
  • 2015 American Transplant Congress

    The Effects of Change in Body Mass Index on Morbidity and Mortality After Liver Transplantation

    B. Kashat,2 A. Prushani,1 S. Jafri.1

    1Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI; 2University of Michigan, Ann Arbor, MI.

    AIM: Typically, a large BMI (body mass index) is associated with poor health as it can lead to a variety of diseases; we investigate frequency…
  • 2015 American Transplant Congress

    Intraoperative Renal Replacement Therapy During Liver and Liver-Kidney Transplant: Outcomes of 155 Cases

    M. Mai,1 E. Golan,2 K. Croome,1 A. Keaveny,1 B. Taner,1 T. Gonwa,1 H. Wadei.1

    1Transplantation, Mayo Clinic, Jacksonville, FL; 2Florida State University, Tallahassee, FL.

    Background: Renal dysfunction in liver (LT) and liver-kidney (LKT) transplant candidates increases intraoperative risks of electrolyte disturbances and volume excess complications. The role of intraoperative…
  • 2015 American Transplant Congress

    Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers

    D. Hoyer,1 A. Gallinat,1 T. Minor,2 F. Saner,1 P. Kocabayoglu,1 J. Treckmann,1 A. Paul.1

    1General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany; 2Surgical Research Division, University Hospital Bonn, Bonn, Germany.

    Background:Since there is no generally accepted standard definition of early allograft dysfunction (EAD) after liver transplantation, we recently suggested postoperative labMELD as predictor for outcome…
  • 2015 American Transplant Congress

    Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score

    J. Lee, J. Lee, D. Joo, D. Han, M. Ju, J. Choi, S. Kim, M. Kim.

    Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.

    BackgroundLiving donor liver transplantation (LDLT) has developed as an alternative to decease donor liver transplantation (DDLT) to overcome the critical shortage of deceased organ donations.…
  • 2015 American Transplant Congress

    Pilot Study on Safety and Feasibility of Complete Meal Replacement in Liver Transplant Recipients and Potential Donors

    F. Bhatti,1 M. Jesse,3 K. George,2 J. Centala,4 J. Ehrman,5 A. Eshelman,3 M. Abouljoud,3 K. Brown.

    1Gastroenterology & Hepatology, Henry Ford Health System, Detroit, MI; 2Internal Medicine, Henry Ford Health System, Detroit, MI; 3Transplant Institute, Henry Ford Health System, Detroit, MI; 4Wayne State University, Detroit, MI; 5Cardiology, Henry Ford Health System, Detroit, MI.

    Background: Metabolic syndrome (MS) and hepatic steatosis (HS) are potential long-term complications after liver transplantation (LT). Post-LT caloric intake normalizes which can result in obesity.…
  • 2015 American Transplant Congress

    Outcomes of Patients With Hepatocellular Carcinoma Receiving a Donation After Cardiac Death Liver Graft

    W. Goldkamp,1 J. Vanatta,2,3 S. Nair,2,3 E. Wong,3 N. Dbouk.2,3

    1Internal Medicine, The Universty of Tennessee Health Science Center, Memphis, TN; 2Surgery, The Universty of Tennessee Health Science Center, Memphis, TN; 3Methodist Universty Hospital Transplant Institute, Memphis, TN.

    Background: Recent data suggests that patients with Hepatocellular carcinoma (HCC) who receive a donation after cardiac death (DCD) graft have inferior graft and patient survival…
  • « Previous Page
  • 1
  • …
  • 167
  • 168
  • 169
  • 170
  • 171
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences